中华全科医师杂志
中華全科醫師雜誌
중화전과의사잡지
CHINESE JOURNAL OF GENERAL PRACTITIONERS
2011年
1期
62-64
,共3页
李方英%华倩%班开斌%黄友敏
李方英%華倩%班開斌%黃友敏
리방영%화천%반개빈%황우민
子宫内膜异位症%高迁移率族蛋白质类
子宮內膜異位癥%高遷移率族蛋白質類
자궁내막이위증%고천이솔족단백질류
Endometriosis%High mobility group proteins
检测76例子宫内膜异位症(EMS)患者(EMS组)(Ⅰ、Ⅱ期36例,Ⅲ、Ⅳ期40例)和30例因卵巢囊肿或浆膜下子宫肌瘤手术患者(对照组)腹腔液及血清高迁移率蛋白-1(HMGB1)、高敏C反应蛋白(Hs-CRP)含量.EMS组患者腹腔液中HMGB1、Hs-CRP的含量明显高于对照组,(8.2±0.8)mg/L比(2.1±0.2)mg/L、(14.4±3.0)mg/L比(4.5±2.3)mg/L(均P<0.01).Ⅲ、Ⅳ期EMS患者腹腔液中HMGB1、Hs-CRP的含量较Ⅰ、Ⅱ期患者升高,(9.2±0.8)mg/L比(6.7±0.7)mg/L、(18.7±2.9)mg/L比(11.2±2.8)mg/L,差异有统计学意义(均P<0. 05),同时Ⅲ、Ⅳ期EMS患者血清中HMGB1、Hs-CRP的含量也高于Ⅰ、Ⅱ期患者,(6.5±0.6)mg/L比(3.4±0.5)mg/L、(8.4±2.7)mg/L比(5.4±2.4)mg/L.同时EMS组患者HMGB1与Hs-CRP的含量之间存在正相关(r=0.72,P<0.01).EMS患者高含量的HMGB1与Hs-CRP可作为判断EMS病情的参考指标.
檢測76例子宮內膜異位癥(EMS)患者(EMS組)(Ⅰ、Ⅱ期36例,Ⅲ、Ⅳ期40例)和30例因卵巢囊腫或漿膜下子宮肌瘤手術患者(對照組)腹腔液及血清高遷移率蛋白-1(HMGB1)、高敏C反應蛋白(Hs-CRP)含量.EMS組患者腹腔液中HMGB1、Hs-CRP的含量明顯高于對照組,(8.2±0.8)mg/L比(2.1±0.2)mg/L、(14.4±3.0)mg/L比(4.5±2.3)mg/L(均P<0.01).Ⅲ、Ⅳ期EMS患者腹腔液中HMGB1、Hs-CRP的含量較Ⅰ、Ⅱ期患者升高,(9.2±0.8)mg/L比(6.7±0.7)mg/L、(18.7±2.9)mg/L比(11.2±2.8)mg/L,差異有統計學意義(均P<0. 05),同時Ⅲ、Ⅳ期EMS患者血清中HMGB1、Hs-CRP的含量也高于Ⅰ、Ⅱ期患者,(6.5±0.6)mg/L比(3.4±0.5)mg/L、(8.4±2.7)mg/L比(5.4±2.4)mg/L.同時EMS組患者HMGB1與Hs-CRP的含量之間存在正相關(r=0.72,P<0.01).EMS患者高含量的HMGB1與Hs-CRP可作為判斷EMS病情的參攷指標.
검측76례자궁내막이위증(EMS)환자(EMS조)(Ⅰ、Ⅱ기36례,Ⅲ、Ⅳ기40례)화30례인란소낭종혹장막하자궁기류수술환자(대조조)복강액급혈청고천이솔단백-1(HMGB1)、고민C반응단백(Hs-CRP)함량.EMS조환자복강액중HMGB1、Hs-CRP적함량명현고우대조조,(8.2±0.8)mg/L비(2.1±0.2)mg/L、(14.4±3.0)mg/L비(4.5±2.3)mg/L(균P<0.01).Ⅲ、Ⅳ기EMS환자복강액중HMGB1、Hs-CRP적함량교Ⅰ、Ⅱ기환자승고,(9.2±0.8)mg/L비(6.7±0.7)mg/L、(18.7±2.9)mg/L비(11.2±2.8)mg/L,차이유통계학의의(균P<0. 05),동시Ⅲ、Ⅳ기EMS환자혈청중HMGB1、Hs-CRP적함량야고우Ⅰ、Ⅱ기환자,(6.5±0.6)mg/L비(3.4±0.5)mg/L、(8.4±2.7)mg/L비(5.4±2.4)mg/L.동시EMS조환자HMGB1여Hs-CRP적함량지간존재정상관(r=0.72,P<0.01).EMS환자고함량적HMGB1여Hs-CRP가작위판단EMS병정적삼고지표.
The concentrations of prostaglandin in high mobility group box-1 ( HMGB1 ) and highsensitive C-reactive protein (Hs-CRP) in serum and peritoneal fluid were detected in 76 patients with endometriosis (study group) and 30 patients without endometriosis (ovary cysts or uterine myoma, as control group). The peritoneal fluids were collected during laparoscopic operation, and the serum samples were collected before surgery. The HMGB1 and Hs-CRP concentrations in serum and peritoneal fluid of study group were significantly higher than those of control group, ( 8. 2 ± 0. 8) mg/L vs. (2. 1 ±. 0. 2) mg/L、 ( 14. 4 ±3.0) mg/L vs. (4.5 ±2.3) mg/L (both P<0. 01);HMGB1 and Hs-CRP levels in serum and peritoneal fluid of stage Ⅲ-Ⅳ endometriosis were significantly higher than those of stage Ⅰ-Ⅱ, ( 9. 2 ± 0. 8) mg/L vs.(6.7 ±0.7) mg/L,(18.7 ±2.9) mg/L vs. (11.2 ±2. 8) mg/L,(6.5 ±0.6) mg/L vs. (3.4 ±0.5) mg/L,(8.4 ±2.7) mg/L vs. (5.4 ±2.4) mg/L (all P <0.05). The concentrations of HMGB1 were positively correlated with Hs-CRP in endometriosis group (r =0. 72, P <0. 01 ). The results indicate that concentrations of HMGB1 and Hs-CRP may be of value in assessing the severity of endometrosis.